Our experiments demonstrated that the combination treatment of Bac-ELP1-H1 and temozolomide acts synergistically to enhance survival in mice and has higher effectiveness in the reduction of tumor progression compared to single treatment with its components. Here, ELP1 is linked to neoplasm.